Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia.
Robertson
M J
MJ
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Roy
D C
DC
Stone
R M
RM
Ritz
J
J
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D016465:Bone Marrow Purging / Q000379:methods*; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003165:Complement System Proteins; D006801:Humans; D000922:Immunotoxins; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D051379:Mice; D016499:Radioimmunotherapy; D063268:Sialic Acid Binding Ig-like Lectin 3; D014182:Transplantation, Autologous
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; C571163:CD33 protein, human; C571165:Cd33 protein, mouse; D000922:Immunotoxins; D063268:Sialic Acid Binding Ig-like Lectin 3; D003165:Complement System Proteins